Membrane transporters

被引:96
作者
Lee, VHL [1 ]
机构
[1] Univ So Calif, Sch Pharm, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA
关键词
PepT1; substrate specificity; trafficking; excipient; drug-drug interaction; drug-nutrient interaction;
D O I
10.1016/S0928-0987(00)00163-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carrier-mediated drug transport is relatively unexplored in comparison with passive transcellular and paracellular drug transport. Yet, there is a host of transporter proteins that can be targeted for improving epithelial drug absorption. Generally, these are transport mechanisms for amino acids, dipeptides, monosaccharides, monocarboxylic acids, organic cations, phosphates, nucleosides, and water-soluble vitamins. Among them, the dipeptide transporter mechanism has received the most attention. Dipeptide transporters are H+-coupled, energy-dependent transporters that are known to play an essential role in the oral absorption of beta -lactam antibiotics, an,angiotensin-converting enzyme (ACE) inhibitors, renin inhibitors, and an anti-tumor drug, bestatin. Moreover, several investigators have demonstrated the utility of the dipeptide transporter as a platform for improving the oral bioavailability of drugs such as zidovudine and acyclovir through dipeptide prodrug derivatization. Thus far, at least four proton-coupled peptide transporters have been cloned. The first one cloned was PepT1 from the rabbit small intestine. The focus of this presentation will be structure-function, intracellular trafficking, and regulation of PepT1. Disease, dietary, and possible excipient influences on PepT1 function will also be discussed. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:S41 / S50
页数:10
相关论文
共 108 条
[81]   Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist [J].
Surendran, N ;
Covitz, KMY ;
Han, HK ;
Sadee, W ;
Oh, DM ;
Amidon, GL ;
Williamson, RM ;
Bigge, CF ;
Stewart, BH .
PHARMACEUTICAL RESEARCH, 1999, 16 (03) :391-395
[82]   MOLECULAR MECHANISM FOR THE RELATIVE BINDING-AFFINITY TO THE INTESTINAL PEPTIDE CARRIER - COMPARISON OF 3 ACE-INHIBITORS - ENALAPRIL, ENALAPRILAT, AND LISINOPRIL [J].
SWAAN, PW ;
STEHOUWER, MC ;
TUKKER, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1236 (01) :31-38
[83]   PH-DEPENDENT AND CARRIER-MEDIATED TRANSPORT OF SALICYLIC-ACID ACROSS CACO-2 CELLS [J].
TAKANAGA, H ;
TAMAI, I ;
TSUJI, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (07) :567-570
[84]   CARRIER-MEDIATED TRANSPORT-SYSTEMS OF TETRAETHYLAMMONIUM IN RAT RENAL BRUSH-BORDER AND BASOLATERAL MEMBRANE-VESICLES [J].
TAKANO, M ;
INUI, K ;
OKANO, T ;
SAITO, H ;
HORI, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 773 (01) :113-124
[85]   PROTON-COTRANSPORT OF PRAVASTATIN ACROSS INTESTINAL BRUSH-BORDER MEMBRANE [J].
TAMAI, I ;
TAKANAGA, H ;
MAEDA, H ;
OGIHARA, T ;
YONEDA, M ;
TSUJI, A .
PHARMACEUTICAL RESEARCH, 1995, 12 (11) :1727-1732
[86]   Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1 [J].
Tamai, I ;
Yabuuchi, H ;
Nezu, J ;
Sai, Y ;
Oku, A ;
Shimane, M ;
Tsuji, A .
FEBS LETTERS, 1997, 419 (01) :107-111
[87]   Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2 [J].
Tamai, I ;
Ohashi, R ;
Nezu, J ;
Yabuuchi, H ;
Oku, A ;
Shimane, M ;
Sai, Y ;
Tsuji, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20378-20382
[88]  
Tanaka H, 1998, GASTROENTEROLOGY, V114, P714, DOI 10.1016/S0016-5085(98)70585-2
[89]   Peptide mimics as substrates for the intestinal peptide transporter [J].
Temple, CS ;
Stewart, AK ;
Meredith, D ;
Lister, NA ;
Morgan, KM ;
Collier, ID ;
Vaughan-Jones, RD ;
Boyd, CAR ;
Bailey, PD ;
Bronk, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :20-22
[90]   N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition [J].
Terada, T ;
Saito, H ;
Sawada, K ;
Hashimoto, Y ;
Inui, K .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :15-20